David Mark McClung

Insider Reports History

Location
Brisbane, CA
Signature
David Mark McClung, by /s/ Ron A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Mark McClung:

Company Role Class Num Shares Value Price $ Report Date Ownership
SANGAMO THERAPEUTICS, INC EVP, Chief Operating Officer Common Stock 212,471 $81,185 $0.3821 25 Nov 2023 Direct

Insider Reports Filed by David Mark McClung

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SGMO SANGAMO THERAPEUTICS, INC 25 Nov 2023 1 -$736 4 EVP, Chief Operating Officer 28 Nov 2023, 16:19
SGMO SANGAMO THERAPEUTICS, INC 25 Aug 2023 1 -$1,482 4 EVP, Chief Operating Officer 29 Aug 2023, 16:15
SGMO SANGAMO THERAPEUTICS, INC 25 Jun 2023 1 -$13,718 4 EVP, Chief Operating Officer 26 Jun 2023, 16:31
SGMO SANGAMO THERAPEUTICS, INC 25 May 2023 1 -$2,560 4 EVP, Chief Operating Officer 30 May 2023, 16:43
SGMO SANGAMO THERAPEUTICS, INC 24 Feb 2023 3 -$25,922 4 EVP, Chief Operating Officer 06 Mar 2023, 16:09
SGMO SANGAMO THERAPEUTICS, INC 25 Jun 2022 1 -$49,673 4 EVP, Chief Operating Officer 28 Jun 2022, 17:25
SGMO SANGAMO THERAPEUTICS, INC 25 Feb 2022 3 -$27,199 4 EVP, Chief Operating Officer 01 Mar 2022, 16:17
SGMO SANGAMO THERAPEUTICS, INC 25 Jun 2021 1 -$138,530 4 EVP, Chief Business Officer 29 Jun 2021, 19:55